Stroke prevention – review of the latest reports
DOI:
https://doi.org/10.12775/JEHS.2023.13.02.037Keywords
stroke, prevention, risk factorsAbstract
Introduction and purpose: According to WHO 15 million people suffer from stroke, one-third of which dies and the other one-third is permanently disabled. For this reason, this condition is a very important medical and social problem. It is one of the leading causes of death, after cardiovascular diseases and cancer. It is also one of the most common causes of disability in the adult population. The economic aspects are related not only to the costs of hospital treatment, but above all to rehabilitation and chronic treatment. The aim of this article is to present the most important stroke risk factors and, based on them, to describe recommendations for effective stroke prevention.
A brief description of the state of knowledge: In recent years, numerous studies have been conducted on the relationship between various factors and the risk of stroke. It turned out that many stroke risk factors are modifiable and by using various methods we are able to significantly reduce the risk of its occurrence. The most important risk factor is the patient's hypertension. Others are cardiovascular diseases such as atrial fibrillation; diabetes, obesity, low level of physical activity, improper diet, consumption of alcohol and tobacco products.
Summary: Through education and promotion of a healthy lifestyle in society (high physical activity, healthy diet, lack of addictions, taking care of mental health and avoiding excessive stress), as well as regular blood pressure and glucose control and effective treatment of conditions leading to stroke, the incidence of stroke among people can actually be reduced. This issue still requires further research and constant expansion of our knowledge.
References
. Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139-e596.
. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):439-458.
. O’Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 2016;388(10046):761–75.
. Feske SK. Ischemic Stroke. Am J Med. 2021 Dec;134(12):1457-1464. doi: 10.1016/j.amjmed.2021.07.027. Epub 2021 Aug 27. PMID: 34454905.
. Zia E., Hedblad B., Pessah-Rasmussen H. i wsp.: . Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage. Hypertensive hemorrhage: debated nomenclature is still relevant. Stroke. 2007 Oct, 38 (10), 2681-5.
. Sokol SI, Kapoor JR, Foody JM: Blood pressure reduction in the primary and secondary prevention of stroke. Curr Vasc Pharmacol 2006;4:155-160.
. Neal B., MacMahon S., Chapman N.: Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure–lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet. 2000, 356, 1955-1964.
. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS: Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003;289:2534-2544.
. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY: A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138:1093-1100.
. Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492-501.
. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, et al: Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-2429.
. Chatterjee, S.et al. 2013. New oral anticoagulants and the risk of intracranial hemorrhage: insights from a traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation. JAMA Neurol. 70: 1486–1490.
. Eikelboom, J.W. et al. 2013. Dabigatran versus warfarin In patients with mechanical heart valves. Engl. J. Med. 369: 1206–1214.
. Koudstaal, P.J. et al. 1993. Secondary prevention in nonrheumatic atrial fibrillation after transient ischemic attaca or minor stroke. Lancet 342: 1255–1262.
. Sandercock, P.A. et al. 2003. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst. Rev. Art. No.: CD000029.
. Healey, J.S. et al. 2008. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). Stroke 39: 1482–1486.
. Goldstein L.B., Adams R., Alberts M.J. i wsp.: American Heart Association/American Stroke Association Stroke Council; Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; Quality of Care and Outcomes Research Interdisciplinary Working Group; American Academy of Neurology. PPrimary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Stroke. 2006, 37, 1583-1633.
. Goldstein L.B., Rothwell P.M.: Advances in prevention and health services delivery 2007.Stroke. 2008 Feb, 39 (2), 258-60.
. Kissela B.M.., Khoury J., Kleindorfer D. i wsp.: Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care. 2005 Feb, 28 (2), 355-9.
. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854-865.
. Goldstein LB, Amarenco P, Szarek M, et al; SPARCL Investigators. Hemorrhagic Stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Study. Neurology 2008;70(24 Pt 2):2364–2370
. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet 1995;346(8991-8992):1647–1653
. Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G. Total and high-density lipoprotein cholesterol and stroke risk. Stroke 2012;43(07):1768–1774
. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001;103(01):163–182
. Koren-Morag N, Tanne D, Graff E, Goldbourt U. Low- and highdensity lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry. Arch Intern Med 2002;162(09):993–999
. Endres M, Heuschmann PU, Laufs U, Hakim AM. Primary prevention of stroke: blood pressure, lipids, and heart failure. Eur Heart J 2011;32(05):545–552
. Endres M: Statins and stroke. J Cereb Blood Flow Metab 2005;25:1093-1110.
. Lee IM, Hennekens CH, Berger K, et al.. Exercise and risk of stroke in male physicians. Stroke 1999;30:1–6. 10.1161/01.STR.30.1.1
. Sacco RL, Gan R, Boden-Albala B, et al.. Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke 1998;29:380–7. 10.1161/01.STR.29.2.380
. Sarikaya H, Ferro J, Arnold M: Stroke Prevention - Medical and Lifestyle Measures. Eur Neurol 2015;73:150-157. doi: 10.1159/000367652
. Willett WC, Stampfer MJ. Rebuilding the food pyramid. Sci Am 2003;288:64–71. 10.1038/scientificamerican0103-64
. Spence JD. Diet for stroke prevention. Stroke Vasc Neurol. 2018 Jan 13;3(2):44-50. doi: 10.1136/svn-2017-000130. PMID: 30022800; PMCID: PMC6047334.
. Strepikowska A., Buciński A. (2009). Udar mózgu - czynniki ryzyka i profilaktyka. Farmacja Pol., T. 65, nr 1, s. 46-50.
. Pandian, J. D., Gall, S. L., Kate, M. P., Silva, G. S., Akinyemi, R. O., Ovbiagele, B. I., … Thrift, A. G. (2018). Prevention of stroke: a global perspective. The Lancet, 392(10154), 1269–1278. doi:10.1016/s0140-6736(18)31269-8
. Hirtz D., Thurman D.J., Gwinn-Hardy K. i wsp.: How common are the „common” neurologic disorders. Neurology, 2007, 68, 326-337.
. Hajat C., Tilling K., Stewart J.A. i wsp.: Ethnic differences in risk factors for ischemic stroke: a European case-control study. Stroke. 2004 Jul, 35 (7),1562-7.
. McGruder H.F., Malarcher A.M., Antoine T.L. i wsp.: Racial and ethnic disparities in cardiovascular risk factors among stroke survivors: United States 1999 to 2001. Stroke. 2004 Jul, 35 (7),1557-61.
. Gromadzka G.: Czynniki genetyczne a udar mózgu. Neurologica et Neurogeriatria. 2002 Wrzesień, 4-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Radosław Kasperski, Małgorzata Piekarska, Katarzyna Pacek, Agata Pikulicka, Izabela Szulc, Klaudia Jedlina, Weronika Swacha, Kamila Świercz
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 385
Number of citations: 0